Related Experiment Video
Updated: May 4, 2026

Establishment of a Clinic-based Biorepository
Published on: May 29, 2017
Patient awareness and approval for an opt-out genomic biorepository
Kyle B Brothers1, Mathew J Westbrook2, M Frances Wright2
1Center for Biomedical Ethics & Society, Vanderbilt University, Nashville, TN, USA ; Department of Pediatrics, Vanderbilt University & the Monroe Carell Jr.Children's Hospital at Vanderbilt, Nashville, TN, USA ; Kosair Charites Pediatric Clinical, Research Unit, Department of Pediatrics, University of Louisville, School of Medicine, Louisville, KY, USA.
Aim:
In this study, we sought to assess patient awareness and perceptions of an opt-out biorepository.
Materials & Methods:
We conducted exit interviews with adult patients and parents of pediatric patients having their blood drawn as part of their clinical care at Vanderbilt University Medical Center (TN, USA).
Results:
32.9% of all patients and parents of pediatric patients report having heard of the opt-out biorepository, while 92.4% approve of this research effort based on a brief description. Awareness that leftover blood could be used for research increased among adult patients during the study period, from 34.3 to 50.0%.
Conclusion:
These findings will inform ongoing assessments of the suitability of opt-out and opt-in methods as alternatives to written informed consent for inclusion in a biorepository.
More Related Videos
08:01Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
06:42Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications
Published on: September 2, 2025
Related Concept Videos
Bioequivalence studies: Biowaivers
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Genomics
Genomic DNA in Eukaryotes
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Pharmacogenomics: Identification of New Drug Targets